E. Weidekamm
Impact in
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Cancer therapeutics and mechanisms 10
- Lipid Membrane Structure and Behavior 9
- Pharmacology 23
- Antibiotics Pharmacokinetics and Efficacy 23
- Co-authors
- Bruno Reigner (9 shared papers)Brigitte Roos (11 shared papers)Karen Smith Blesch (1 shared paper)Jim Cassidy (7 shared papers)Ludger Banken (7 shared papers)Masahiro Utoh (4 shared papers)Donald F. H. Wallach (8 shared papers)Étienne Dumont (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (12 papers)Biochimica et Biophysica Acta (BBA) - Biomembranes (9 papers)Cancer Chemotherapy and Pharmacology (5 papers)Archives of Biochemistry and Biophysics (3 papers)European Journal of Clinical Pharmacology (3 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
E. Weidekamm
61 papers receiving 2.6k citations
E. Weidekamm's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 1.1k
- Molecular Medicine 137
- Pharmacology 374
- Infectious Diseases 408
- Dermatology 134
Countries citing papers authored by E. Weidekamm
This map shows the geographic impact of E. Weidekamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Weidekamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Weidekamm more than expected).
Fields of papers citing papers by E. Weidekamm
This network shows the impact of papers produced by E. Weidekamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Weidekamm. The network helps show where E. Weidekamm may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Weidekamm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients Hit paper breakdown → | 2000 | 547 |
| 2 | 2001 | 319 | |
| 3 | 2005 | 140 | |
| 4 | Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. | 1998 | 138 |
| 5 | Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites. | 1999 | 123 |
| 6 | 2005 | 118 | |
| 7 | 2002 | 103 | |
| 8 | 2004 | 87 | |
| 9 | 1987 | 83 | |
| 10 | Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting. | 1982 | 79 |
| 11 | 2004 | 70 | |
| 12 | 1970 | 69 | |
| 13 | 1999 | 62 | |
| 14 | 1973 | 60 | |
| 15 | 2005 | 56 | |
| 16 | 1973 | 50 | |
| 17 | 1972 | 47 | |
| 18 | 2003 | 41 | |
| 19 | 1974 | 40 | |
| 20 | 2002 | 36 |
About E. Weidekamm
E. Weidekamm is a scholar working on Molecular Biology, Pharmacology, Oncology, Epidemiology and Pediatrics, Perinatology and Child Health, having authored 61 papers that have together received 2.8k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Cancer therapeutics and mechanisms (10 papers), Lipid Membrane Structure and Behavior (9 papers), Antibiotic Resistance in Bacteria (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Erythrocyte Function and Pathophysiology (5 papers), Pneumonia and Respiratory Infections (4 papers) and Neonatal Health and Biochemistry (4 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Medicine (137 citations), Pharmacology (374 citations), Infectious Diseases (408 citations) and Dermatology (134 citations). E. Weidekamm has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Bruno Reigner, Brigitte Roos, Karen Smith Blesch, Jim Cassidy, Ludger Banken, Masahiro Utoh, Donald F. H. Wallach, Étienne Dumont, Sarah Durston and Kazushige Mori. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Biochimica et Biophysica Acta (BBA) - Biomembranes, Cancer Chemotherapy and Pharmacology, Archives of Biochemistry and Biophysics and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.